Related Experiment Video
Updated: Mar 12, 2026

09:01
Flow Cytometric Analysis of Lymphocyte Infiltration in Central Nervous System during Experimental Autoimmune Encephalomyelitis
Published on: November 17, 2020
7.8K
Th9 cells in the pathogenesis of EAE and multiple sclerosis
Wassim Elyaman1, Samia J Khoury2,3
1Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital and Harvard Medical School, 77 Avenue Louis Pasteur, Boston, MA, 02115, USA. welyaman@rics.bwh.harvard.edu.
Seminars in Immunopathology
|November 16, 2016
Summary
Interleukin-9 (IL-9) producing CD4+ T helper cells (Th9) play a key role in autoimmune diseases like multiple sclerosis (MS). This review details Th9 cell regulation and IL-9 signaling in experimental autoimmune encephalomyelitis (EAE), an MS model.
Area of Science:
- Immunology
- Neuroscience
Background:
- CD4+ T helper 9 (Th9) cells are a recently identified T helper subset.
- Interleukin-9 (IL-9) is a pleiotropic cytokine with diverse immune and central nervous system (CNS) effects.
- Th9 cells and IL-9 signaling are increasingly recognized for their roles in autoimmune conditions.
Purpose of the Study:
- To review the current understanding of Th9/IL-9 signaling in experimental autoimmune encephalomyelitis (EAE) and multiple sclerosis (MS).
- To summarize the in vivo sources and regulation of Th9 cells.
- To examine the impact of IL-9 signaling on immune cells in EAE and its association with MS.
Main Methods:
- Literature review focusing on Th9 cells, IL-9, EAE, and MS.
- Synthesis of existing research on Th9 cell biology and function.
- Analysis of the role of IL-9 in autoimmune CNS inflammation.
Main Results:
- IL-9, initially linked to type 2 inflammation, is now understood to be crucial in regulating autoimmune responses.
- Th9 cells and IL-9 signaling influence both peripheral and CNS-resident cells during EAE.
- Evidence suggests a significant association between IL-9 and MS disease activity.
Conclusions:
- Th9/IL-9 signaling is a critical factor in the pathogenesis of EAE and potentially MS.
- Further research into Th9 cell regulation and IL-9's mechanisms is warranted for understanding and treating MS.
- Targeting Th9/IL-9 pathways may offer novel therapeutic strategies for multiple sclerosis.

